Androgenetic alopecia (AGA) or male pattern baldness is the most common form of hair loss in humans. Despite being a very frequent dermatological entity, molecular pathophysiology remains unclear. Several authors relate the presentation of AGA with a premature apoptotic process during the anagen phase and with an inflammatory microenvironment in the hair follicle. We evaluated a panel of 30 genes associated with inflammation and apoptosis in 5 AGA patients by targeted RNA-Seq. WNT7A gene was highly expressed in patients in stages 3V to 5 on the Hamilton-Norwood scale compared to patients with 5A stage. CASP7 and TNF genes were overexpressed in stages 3V and 4 compared to stages 5 and 5A. Overexpression of these genes detected only at early stages of AGA proves the role of WNT pathway, apoptosis, and inflammation in the development of this disorder.

Keywords:
Androgenetic alopecia, Targeted RNA-Seq, Apoptosis, Inflammation
1.
Heilmann S, Brockschmidt FF, Hillmer AM, Hanneken S, Eigelshoven S, Ludwig KU, Herold C, Mangold E, Becker T, Kruse R, Knapp M, Nothen MM: Evidence for a polygenic contribution to androgenetic alopecia. Br J Dermatol 2013;169:927-930.
2.
Murphy GF: Mechanism of apoptotic regulation of follicular regression: toward understanding the molecular basis for tissue remodeling and regeneration. Am J Pathol 2001;158:1899-1901.
3.
Hibino T, Nishiyama T: Role of TGF-beta2 in the human hair cycle. J Dermatol Sci 2004;35:9-18.
4.
Restrepo R: Anatomía microscópica del folículo piloso. Rev Asoc Colomb Dermatol 2010;18:123-138.
5.
Prieto VG, Sadick NS, Shea CR: Androgenetic alopecia: analysis of proliferation and apoptosis. Arch Dermatol 2002;138:1101-1102.
6.
Guzmán-Sánchez DA: Alopecia Androgenética. Dermatol Rev Mex 2015;59:387-394.
7.
Sawaya ME, Blume-Peytavi U, Mullins DL, Nusbaum BP, Whiting D, Nicholson DW, Lotocki G, Keane RW: Effects of finasteride on apoptosis and regulation of the human hair cycle. J Cutan Med Surg 2002;6:1-9.
8.
Vladimir Denisov WS, Walder M, Gingrich J, Henri Wintz H: Development and Validation of RQI: An RNA Quality Indicator for the ExperionTM Automated Electrophoresis System. California, Bio-Rad Laboratories, 2008.
9.
Lamkanfi M, Kanneganti TD: Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol 2010;42:21-24.
10.
Takahashi T, Ogo M, Hibino T: Partial purification and characterization of two distinct types of caspases from human epidermis. J Invest Dermatol 1998;111:367-372.
11.
Soma T, Ogo M, Suzuki J, Takahashi T, Hibino T: Analysis of apoptotic cell death in human hair follicles in vivo and in vitro. J Invest Dermatol 1998;111:948-954.
12.
Vesela B, Svandova E, Vanden Berghe T, Tucker AS, Vandenabeele P, Matalova E: Non-apoptotic role for caspase-7 in hair follicles and the surrounding tissue. J Mol Histol 2015;46:443-455.
13.
Zhang JM, An J: Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007;45:27-37.
14.
Gruss HJ, Dower SK: Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-3404.
15.
Fabre C, Dereure O: Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab. Dermatology 2008;216:185-186.
16.
Salvesen GS: Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 2002;9:3-5.
17.
Fawzi MM, Mahmoud SB, Shaker OG, Saleh MA: Assessment of tissue levels of dickkopf-1 in androgenetic alopecia and alopecia areata. J Cosmet Dermatol 2016;15:10-15.
18.
Chang TP, Vancurova I: Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma. Biochim Biophys Acta 2014;1843:2620-2630.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.